WordNet
- weight down with a load (同)burthen, weight, weight down
- an onerous or difficult concern; "the burden of responsibility"; "thats a load off my mind" (同)load, encumbrance, incumbrance, onus
- the central idea that is expanded in a document or discourse
- bearing a heavy burden of work or difficulties or responsibilities; "she always felt burdened by the load of paper work"
- bearing a physically heavy weight or load; "tree limbs burdened with ice"; "a heavy-laden cart"; "loaded down with packages" (同)heavy-laden, loaded down
- an abnormal new mass of tissue that serves no purpose (同)tumour, neoplasm
PrepTutorEJDIC
- 〈C〉『荷物』,『積荷』 / 〈U〉荷物の運搬 / 〈C〉(…にとっての)(心を)『重荷』,苦しみ,悩み《+『to』(『on』)+『名』》 / (荷を)…‘に'『負わせる』,積む《+『名』~『with』+『名』〈荷〉》
- 〈C〉(歌の)折り返し / 《the ~》くり返し説かれる要旨(主旨)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy.
- Rusckowski M1, Wang Y, Blankenberg FG2, Levashova Z2,3, Backer MV4, Backer JM5.
- EJNMMI research.EJNMMI Res.2016 Dec;6(1):4. doi: 10.1186/s13550-016-0163-1. Epub 2016 Jan 16.
- BACKGROUND: scVEGF/(177)Lu is a novel radiopharmaceutical targeted by recombinant single-chain (sc) derivative of vascular endothelial growth factor (VEGF) that binds to and is internalized by vascular endothelial growth factor receptors (VEGFR). scVEGF/(177)Lu potential as adjuvant and neoadjuvant
- PMID 26780081
- Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches.
- Di Francesco AM1, Toesca A2, Cenciarelli C3, Giordano A4, Gasbarrini A5, Puglisi MA5.
- Journal of cellular physiology.J Cell Physiol.2016 Oct;231(10):2081-7. doi: 10.1002/jcp.25318. Epub 2016 Feb 2.
- Currently, there is much interest in the characterization of metabolic profiling of cancer stem cells (CSCs), a small subset of tumor cells with self-renewal capacity. Indeed, ever-growing evidence indicate that metabolism and stemness are highly intertwined processes in tumor tissue. In this review
- PMID 26791139
- Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial.
- Gravis G1, Boher JM2, Joly F3, Soulié M4, Albiges L5, Priou F6, Latorzeff I7, Delva R8, Krakowski I9, Laguerre B10, Rolland F11, Théodore C12, Deplanque G13, Ferrero JM14, Culine S15, Mourey L16, Beuzeboc P17, Habibian M18, Oudard S19, Fizazi K5; GETUG.
- European urology.Eur Urol.2016 Aug;70(2):256-62. doi: 10.1016/j.eururo.2015.11.005. Epub 2015 Nov 21.
- BACKGROUND: The role of chemotherapy in metastatic non castrate prostate cancer (mNCPC) is debated. Survival benefits of docetaxel (D) added to androgen-deprivation therapy (ADT) were shown in the CHAARTED trial in patients with metastatic high-volume disease (HVD).OBJECTIVE: To assess the impact of
- PMID 26610858
Japanese Journal
- 低悪性度リンパ腫 : 治療の進歩とその課題 (第77回日本血液学会学術集会 教育講演特集号) -- (リンパ系腫瘍 : ALL/ML)
- 再発・難治性DLBCL治療におけるFDG-PETの役割
Related Pictures
★リンクテーブル★
[★]
- 英
- tumor burden、tumor volume、tumor mass、tumor load
- 関
- 腫瘍体積
[★]
- 関
- tumor burden、tumor load、tumor volume
[★]
- 関
- tumor burden、tumor mass、tumor volume
[★]
- 関
- tumor burden、tumor load、tumor mass
[★]
- 関
- afflict、bother、charge、distress、pressure、trouble
[★]